Mapmygenome, a molecular diagnostics company has tied up with Digital DNAtix Ltd, an Israel-based blockchain genetics company to give a fillip to the way people can use their personal genome data in healthcare.
The Israeli firm has a direct to consumer (D2C) platform, which provides the full range of genome testing and access to services and solutions on the blockchain.
Advantages
The platform facilitates a person to anonymously upload partial or full genome sequences onto the platform. Thereafter, have access to the data to make informed decisions. Secondly, it links individual users in search of genetically-based health and lifestyle solutions with products and services that fit their needs.
For scientific work, the platform allows researchers to use the anonymous DNA stored to create tests, research and design new treatments , says Ofer A Lidsky, Chief Executive Officer of DNAtix.
Mapmygenome, the Hyderabad-based firm at present offers a range of genetic tests. With this collaboration it will be able to extend users the flexibility to explore their genetic makeup in new ways with security and anonymity as a top priority. “It will give more power to consumer to ensure security of personal, genetic data”, Anu Acharya, CEO of the company told BusinessLine.
In addition to enhancing security of crucial genetic data, the collaboration is a step towards empowering the masses with the promise of personal genomics, which in turn is expected to lead to preventive, predictive, precise and personalised medicine, she added.
“India is an important market for the use of DNAtix blockchain-based genetic services, based on population numbers alone. Mapmygenome is a major player in the field of genetics and this partnership opens up a tremendous opportunity to help more people really utilisze genetic testing and research,” said Lidsky in a statement.